Intrinsic Value of S&P & Nasdaq Contact Us

908 Devices Inc. MASS NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
73/100
4/7 Pass
SharesGrow Intrinsic Value
$15.40
+109%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

908 Devices Inc. (MASS) trades at a trailing P/E of 12.9. Trailing earnings yield is 7.74%. Graham Number is $6.93.

Criteria proven by this page:

  • VALUE (93/100, Pass) — P/E is below market average (12.9); earnings yield beats bond yields (7.74%).
  • Trailing Earnings Yield 7.74% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.

Overall SharesGrow Score: 73/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
73/100
SG Score
View full scorecard →
VALUE
93/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
41/100
→ Income
~
GROWTH
55/100
→ Income
INCOME
100/100
→ Income

Valuation Snapshot — MASS

Valuation Multiples
P/E (TTM)12.9
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.75
P/S Ratio4.62
EV/EBITDA-6.4
Per Share Data
EPS (TTM)$0.54
Book Value / Share$3.97
Revenue / Share$1.55
FCF / Share$-0.68
Yields & Fair Value
Earnings Yield7.74%
Dividend Yield0.00%
Graham Number$6.93
SharesGrow IV$15.40 (+109%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2018 -52.8 0.00 -7.93 18.04 -
2019 -27.6 -0.24 -5.84 20.53 -
2020 -24.4 -1.49 2.25 11.61 -
2021 -32.6 0.49 3.37 17.14 -
2022 -7.1 -0.20 1.26 5.12 -
2023 -9.9 -1.77 2.18 7.20 -
2024 -1.0 -0.01 0.65 1.26 -
2025 9.8 -0.08 1.32 3.38 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2018 $-0.40 $22.05M $-7.54M -34.2%
2019 $-0.58 $17.97M $-15.2M -84.6%
2020 $-0.25 $26.89M $-6.94M -25.8%
2021 $-0.79 $42.21M $-22.12M -52.4%
2022 $-1.01 $46.85M $-31.74M -67.8%
2023 $-1.13 $50.23M $-36.4M -72.5%
2024 $-2.12 $59.63M $-72.21M -121.1%
2025 $0.54 $56.2M $19.49M 34.7%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.42 $-0.61 – $-0.21 $65.93M $64.9M – $66.83M 2
2027 $-0.31 $-0.51 – $-0.08 $78.07M $76.9M – $79.36M 2
2028 $-0.36 $-0.37 – $-0.35 $86.8M $85.5M – $88.04M 1
2029 $-0.20 $-0.20 – $-0.20 $101.8M $100.28M – $103.25M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message